admin

The US Food and Drug Administration (FDA) today approved the combination of nivolumab (Opdivo, Bristol-Myers Squibb) plus ipilimumab (Yervoy, Bristol-Myers Squibb) as first-line treatment for patients with metastatic non-small-cell lung cancer (NSCLC) whose tumors express PD-L1 (≥ 1%). Use is limited to patients with no epidermal growth factor receptor or anaplastic lymphoma kinase genomic tumor
0 Comments
The COVID-19 pandemic has completely changed lives. Schools, universities, offices and public spaces have suddenly shut, along with the imposition of social-distancing and travel restrictions everyone must face. Unemployment, economic downfall, shortage of medical equipment and rise in deaths are currently contributing to widespread distress in the United States.   According to a recent study conducted by
0 Comments
Reviewed by Emily Henderson, B.Sc.May 15 2020 People who have experienced maltreatment during childhood are significantly more likely to develop conditions such as heart disease, high blood pressure and type two diabetes in adulthood, a new UK study has found. Childhood maltreatment, which includes any form of physical, sexual or emotional abuse or neglect experienced
0 Comments
Homologous recombination deficiency (HRD) scoring failed to predict PARP inhibitor response in BRCA wild-type ovarian cancer, as women with low scores still appeared to derive benefit, an exploratory analysis of a phase III trial showed. Among 221 patients in the HRD subgroup of VELIA, median progression-free survival (PFS) was 23 months when the investigational PARP
0 Comments
Vulvovaginal atrophy (atrophic vaginitis) affects roughly a third of breast cancer survivors and negatively impacts their quality of life in multiple ways. The condition can lead to thinning, drying, and inflammation of the vaginal walls and typically occurs when the body produces less estrogen than normal. It can make daily life and activities uncomfortable, and
0 Comments
The COVID-19 outbreak presents unique challenges for those of us living with diabetes.  Charlie Kimball, a professional IndyCar driver and father of two and lives with type 1 diabetes. His sport (and job!) is now on hold, and he is home trying to manage his diabetes, eat healthily and stay fit, all the while adjusting
0 Comments
During this virus pandemic, the last thing anyone should worry about is filling and receiving prescriptions, especially if you rely on them to treat serious or chronic conditions. Experts recommend keeping several weeks’ worth of prescriptions you take regularly on hand in the event that you need to stay home, due to illness or shelter-in-place
0 Comments
President Donald Trump speaks about the coronavirus in the Rose Garden of the White House, Friday, May 15, 2020, in Washington. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, right, and White House coronavirus response coordinator Dr. Deborah Birx listen. Alex Brandon | AP President Donald Trump said the the
0 Comments
A novel telemedicine approach to remotely guide ST-segment elevation myocardial infarction treatment in four Latin American countries screened more than 780,000 patients and resulted in a mortality rate of 5.2%, results from a 1-year, prospective, observational study showed. “We have created a modality where the care of acute MI can be remotely guided,” lead investigator
0 Comments
During this virus pandemic, the last thing anyone should worry about is filling and receiving prescriptions, especially if you rely on them to treat serious or chronic conditions. Experts recommend keeping several weeks’ worth of prescriptions you take regularly on hand in the event that you need to stay home, due to illness or shelter-in-place
0 Comments
Print this page KENILWORTH, N.J.–(BUSINESS WIRE) May 13, 2020 –Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced first-time results from a Phase 2 trial evaluating the hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor MK-6482, a novel investigational candidate in Merck’s oncology pipeline, for the treatment of von Hippel-Lindau (VHL) disease-associated clear
0 Comments
A polygenic risk score based on analysis of 29 discrete genetic variants linked with abdominal aortic aneurysms appeared better than the current criteria that clinicians use to identify people to screen for this disorder, potentially paving the way for more efficient use of screening resources. Future screening guidelines for abdominal aortic aneurysms (AAA) “should consider
0 Comments
Last week, I needed to get some labs drawn. I’m not going to lie, I was terrified and anxious about going back to the hospital. Was I risking exposure to COVID by going in? How could I keep myself safe? I kept myself up much of the night before. Tossing, turning, playing out every possible
0 Comments
This content originally appeared on Beyond Type 1. Republished with permission. By Erin McShay Sometimes in life, it takes something bad to happen for us to pause and appreciate how good things once were. I used to think of our lives as before and after our Sam was diagnosed with type 1 diabetes. Fast forward
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The number of COVID-19 deaths cannot be directly compared to the number of seasonal influenza deaths because they are calculated differently, researchers say in a report released today. Whereas COVID-19 death rates are determined from actual counts of people who have
0 Comments